Sichuan Hebang Biotechnology Co., Ltd. (603077) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sichuan Hebang Biotechnology Co., Ltd.

Why is Sichuan Hebang Biotechnology Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 7.31% and Operating profit at -191.24% over the last 5 years

The company has declared Negative results for the last 10 consecutive quarters

NET PROFIT(HY) At CNY -177.34 MM has Grown at -160.32%
ROCE(HY) Lowest at 0.08%
INVENTORY TURNOVER RATIO(HY) Lowest at 1.6%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 7.48%, its profits have fallen by -125.3%
At the current price, the company has a high dividend yield of 1

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sichuan Hebang Biotechnology Co., Ltd. for you?

Medium Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Sichuan Hebang Biotechnology Co., Ltd.

-100.0%

0.70

32.83%

China Shanghai Composite

15.19%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

7.31%

EBIT Growth (5y)

-191.24%

EBIT to Interest (avg)

33.91

Debt to EBITDA (avg)

0.84

Net Debt to Equity (avg)

0.11

Sales to Capital Employed (avg)

0.39

Tax Ratio

2.14%

Dividend Payout Ratio

526.32%

Pledged Shares

Institutional Holding

ROCE (avg)

12.99%

ROE (avg)

9.56%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.91

EV to EBIT

-80.08

EV to EBITDA

25.14

EV to Capital Employed

0.92

EV to Sales

2.48

PEG Ratio

Dividend Yield

1.05%

ROCE (Latest)

-1.15%

ROE (Latest)

-1.18%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

PRE-TAX PROFIT(Q)

At CNY 22.64 MM has Grown at 254.47%

RAW MATERIAL COST(Y)

Fallen by -24.62% (YoY

CASH AND EQV(HY)

Highest at CNY 14,119.82 MM

NET PROFIT(Q)

At CNY 12.52 MM has Grown at 59.13%

-35What is not working for the Company

NET PROFIT(HY)

At CNY -177.34 MM has Grown at -160.32%

ROCE(HY)

Lowest at 0.08%

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.6%

NET SALES(Q)

Lowest at CNY 1,710.43 MM

INTEREST(Q)

Highest at CNY 27.56 MM

Here's what is working for Sichuan Hebang Biotechnology Co., Ltd.

Pre-Tax Profit

At CNY 22.64 MM has Grown at 254.47%

over average net sales of the previous four periods of CNY -14.65 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 12.52 MM has Grown at 59.13%

over average net sales of the previous four periods of CNY 7.87 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Cash and Eqv

Highest at CNY 14,119.82 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by -24.62% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Sichuan Hebang Biotechnology Co., Ltd.

Net Sales

At CNY 1,710.43 MM has Fallen at -19.3%

over average net sales of the previous four periods of CNY 2,119.56 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Interest

At CNY 27.56 MM has Grown at 321.2%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Inventory Turnover Ratio

Lowest at 1.6% and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Net Sales

Lowest at CNY 1,710.43 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Interest

Highest at CNY 27.56 MM

in the last five periods and Increased by 321.2% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Non Operating Income

Highest at CNY 0.79 MM

in the last five periods

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating income